Countdown to IPBC Korea 2023
Just one month until IP leaders will gather in Seoul for an agenda tackling policy developments, market trends, and commercial pressures
Just one month until IP leaders will gather in Seoul for an agenda tackling policy developments, market trends, and commercial pressures
Opinion: Popular attacks on America’s life sciences patent system are highly misleading
Chief IP officers at large and small companies – especially life sciences – are closely watching the case which promises to settle debate about what comprises sufficient enablement under Section 112
As gene editing techniques come to the fore in the UK and elsewhere, Joel Smith of Hogan Lovells argues that industry needs clarity on the breeder's exception to plant variety rights
12 May 2022
Comments sought on draft changes to resource, which come just weeks after parent ministry METI issued FRAND guidelines of its own
11 May 2022
Domestic filings outnumbered foreign ones for the first time in 11 years last quarter, in the latest indication that India’s companies are coming to the patent party
07 May 2022
Compromise agreed by the US, India, the EU and South Africa leaves trade secrets alone but approves measures that would make it faster and easier to bypass vaccine patents
05 May 2022
After getting a chance to hear from the US president’s pick to lead the USPTO, respondents to IAM’s insight panel swung from negative to neutral
02 May 2022
The first pronouncements from new USPTO Director Kathi Vidal are the latest indication that the centre of gravity in IP debate and policy-making has shifted significantly
30 April 2022
Patent litigators who represent plaintiffs and defendants agree the new standing order favours the defence, but one litigation financier predicts well-financed patentees backed by reputable lenders will get the upper hand
29 April 2022
Nikki Price Shaffer and Bob Pechman share insights on how the computer storage company is using data to understand and address the patent inclusion gap
29 April 2022
Company’s general counsel suggests USPTO fees for the largest filers, like the search giant itself, should be raised
29 April 2022
In some of her first public remarks, USPTO director hints at concrete actions the agency could soon take to address perceived patent abuses in life sciences
28 April 2022
Unlock unlimited access to all IAM content